The following products have been found matching your search "his": 439
 Or did you mean: FIND ME THIS PAPER Ball et al. (2022): This study highlights the increased incidence of hypoglycemic episodes in diabetic patients, particularly those with Type 1 diabetes, due to disruptions in glucose homeostasis during fasting periods. The study unders | this | sophisticated | his6 | histocompatibility | histogenetically | polymorphisms | histiocytoma 
   No results were found for the filter! 
  FITC 
    CyFlow™ CD13 FITC    
      
  | Antigen: | CD13 | 
| Clone: | WM15 | 
| Regulatory Status: | ASR | 
| Target Species: | Human | 
  $410.00 USD  
  PE 
   APC 
   PE-Cy7 
    CyFlow™ CD13 PE-Cy7    
      
  | Antigen: | CD13 | 
| Clone: | WM15 | 
| Regulatory Status: | ASR | 
| Target Species: | Human | Quantity: | 100 tests | 
  $495.00 USD  
  PerCP-Cy5.5 
    CyFlow™ CD123 PerCP-Cy5.5    
      
  | Antigen: | CD123 | 
| Clone: | 6H6 | 
| Regulatory Status: | ASR | 
| Target Species: | Human | 
  $595.00 USD  
  PerCP-Cy5.5 
    CyFlow™ CD13 PerCP-Cy5.5    
      
  | Antigen: | CD13 | 
| Clone: | WM15 | 
| Regulatory Status: | ASR | 
| Target Species: | Human | 
  $595.00 USD  
  FITC 
    CyFlow™ CD123 FITC    
      
  | Antigen: | CD123 | 
| Clone: | 6H6 | 
| Regulatory Status: | ASR | 
| Target Species: | Human | 
  $410.00 USD  
  PE-DyLight™ 594 
    CyFlow™ CD13 PE-DyLight™ 594    
      
  | Antigen: | CD13 | 
| Clone: | WM15 | 
| Regulatory Status: | ASR | 
| Target Species: | Human | 
  $595.00 USD  
  PE 
   PE-DyLight™ 594 
    CyFlow™ CD123 PE-DyLight™ 594    
      
  | Antigen: | CD123 | 
| Clone: | 6H6 | 
| Regulatory Status: | ASR | 
| Target Species: | Human | 
  $595.00 USD